Caris Life Sciences (CAI) Shares Outstanding (Entity) (2024 - 2026)

Caris Life Sciences (CAI) Shares Outstanding (Entity) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Caris Life Sciences 6.16 Bn 5.37 Bn 182.38 Mn 282.58 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 282.58 Mn
Mar 31, 2026 284.26 Mn
Dec 31, 2025 167.21 Mn
Sep 30, 2025 283.72 Mn
Jun 30, 2025 64.92 Mn
Mar 31, 2025 35.24 Mn
Dec 31, 2024 36.69 Mn
Sep 30, 2024 35.82 Mn
Jun 30, 2024 35.42 Mn